Erythromycin News and Research

RSS

Erythromycin is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people who have an allergy to penicillins. For respiratory tract infections, it has better coverage of atypical organisms, including mycoplasma and Legionellosis. Erythromycin is an antibiotic produced from a strain of Streptomyces erythraeus.

Biochar from agricultural waste products shows promise for removing pharmaceuticals contaminants

Biochar -- a charcoal-like substance made primarily from agricultural waste products -- holds promise for removing emerging contaminants such as pharmaceuticals from treated wastewater.

17 Nov 2020

Exercise equipment in communal gyms have high levels of antibiotic-resistant bacteria

Research presented at ASM Microbe Online found that 43% of Staphylococcus bacteria found on exercise equipment in university gyms were ampicillin-resistant, with 73% of those isolates being resistant to multiple additional drugs.

24 Jul 2020

Raw-type dog food contains high levels of multidrug-resistant bacteria

Microorganisms that infect animals, such as dogs, have the potential to jump to humans and cause illness. Zoonosis is a disease that can spread from animals to humans. These diseases pose health risks, mainly that some types can become life-threatening. Now, a study warns that raw-type dog food contains high levels of multidrug-resistant bacteria, which has the potential of transmitting the bacteria between dogs and humans.

21 Apr 2020

Macrolide, penicillin antibiotics in pregnancy could affect children’s health

A new study published in the journal BMJ in February 2020 reports that macrolide or penicillin antibiotic consumption in pregnancy could be linked to several adverse health outcomes in children. These include major malformations, cerebral palsy, attention deficit hyperactivity disorder, and autism spectrum disorder.

20 Feb 2020

Americans are taking fish antibiotics to save money

Alarming results from a new study show that people in the United States buying fish antibiotics online and consuming them because they’re more affordable than to go visit a doctor. The study sheds light on the high costs of health care in the country and how citizens are struggling to afford basic services.

12 Dec 2019

Antibiotic resistance in dolphins mirrors disturbing trend in humans

Antibiotic resistance in bottlenose dolphins shows that up to 88% of pathogenic organisms in this species is resistant to one or more antibiotics. This finding offers very useful insights into the identical phenomenon in humans. This species is termed a sentinel species, which means it reflects environmental risks to humans in advance of their occurrence in humans.

16 Sep 2019

Thames typical of superbug-breeding rivers, says new study

The River Thames is rapidly becoming a breeding pool for antibiotic-resistant bacteria, according to a new study, which underlines the urgent need to cut down the amount of antibiotics currently being discharge into the river by at least 80% to arrest this trend.

5 Sep 2019

Women and older adults at increased risk of dangerous drug interactions

A new study led by researchers at Indiana University has found that women and older adults who use multiple prescription drugs are significantly more likely to be prescribed pills whose combination produces dangerous side effects.

12 Aug 2019

London's canals and ponds contain high levels of antibiotic-resistant genes

Central London's freshwater sources contain high levels of antibiotic resistant genes, with the River Thames having the highest amount, according to research by UCL.

26 Jul 2019

Antibiotic levels in water and potential risk of drug-resistant bugs

A JRC report brings together data on antibiotic levels in water, showing that small concentrations have found their way into a range of Europe's waterbodies.

27 Mar 2019

New approach helps clinicians to decide most effective antibiotic treatment courses

A scientific team from Case Western Reserve University School of Medicine and Cleveland Clinic has developed a new way to identify second-line antibiotics that may be effective in killing germs already resistant to a first-line antibiotic - potentially helping overcome antibiotic resistance.

31 Jan 2019

Drug development options diversified with new manganese catalyst

A University of Illinois team of researchers led by chemistry professor M. Christina White has developed a new manganese-based catalyst that can change the structure of druglike molecules to make new drugs, advancing the pace and efficiency of drug development.

9 Jan 2019

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Vertex Pharmaceuticals Incorporated today announced the U.S. Food and Drug Administration approved KALYDECO® (ivacaftor) to include use in children with cystic fibrosis ages 12 to <24 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene that is responsive to KALYDECO based on clinical and/or in vitro assay data.

16 Aug 2018

Changes in bacterial environment may predict risk of preterm birth

A recent study has found that changes in microbial communities within the reproductive tract of pregnant women were strongly linked to premature birth.

26 Jan 2018

Changes in vaginal bacteria associated with premature births

Changes to the communities of microbes living in the reproductive tract of pregnant women could help to spot those at risk of giving birth prematurely.

24 Jan 2018

Study finds increasing susceptibility of Staphylococcus aureus in U.S. hospital patients

Findings from a study that looked at susceptibility trends of Staphylococcus aureus in U.S. hospital patients showed that key antibiotics used to treat the bacteria became more active over the course of the study, a rare occurrence.

5 Jun 2017

Swiss researchers discover potential way to design new antibiotics

Two Swiss research teams from the University of Bern and the ETH Zurich have developed a new method to shed light onto a mostly unknown process of bacterial protein production. Their results could be used for the design of new antibiotics.

10 May 2017

Researchers unravel how drug interacts with ribosome to halt protein production

The discovery of a chemical compound that halts the production of a small set of proteins while leaving general protein production untouched suggests a new drug search strategy: Find compounds that target undesired proteins before they are even made.

23 Mar 2017

Researchers find way to make changes to enzyme-driven assembly line to improve antibiotics

Researchers from North Carolina State University have discovered a way to make pinpoint changes to an enzyme-driven "assembly line" that will enable scientists to improve or change the properties of existing antibiotics as well as create designer compounds.

30 Nov 2016